Raymond J. Henley Iii

Array ( [id] => 3701914 [patent_doc_number] => 05646180 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Treatment of the CNS effects of HIV' [patent_app_type] => 1 [patent_app_number] => 8/567199 [patent_app_country] => US [patent_app_date] => 1995-12-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5569 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/646/05646180.pdf [firstpage_image] =>[orig_patent_app_number] => 567199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3761600 [patent_doc_number] => 05741806 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-21 [patent_title] => 'Suppository compositions containing ondasetron dihydrate' [patent_app_type] => 1 [patent_app_number] => 8/537950 [patent_app_country] => US [patent_app_date] => 1995-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1848 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/741/05741806.pdf [firstpage_image] =>[orig_patent_app_number] => 537950 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3692443 [patent_doc_number] => 05604254 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-18 [patent_title] => 'Indole derivative having prolonged immunostimulating activity and pharmaceutical compositions therefrom' [patent_app_type] => 1 [patent_app_number] => 8/448511 [patent_app_country] => US [patent_app_date] => 1995-12-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 642 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/604/05604254.pdf [firstpage_image] =>[orig_patent_app_number] => 448511 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3516930 [patent_doc_number] => 05576349 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-19 [patent_title] => 'Retionoic acid treatment of cardiac arrhythmia' [patent_app_type] => 1 [patent_app_number] => 8/565160 [patent_app_country] => US [patent_app_date] => 1995-11-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 9 [patent_no_of_words] => 5557 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 88 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/576/05576349.pdf [firstpage_image] =>[orig_patent_app_number] => 565160 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3624457 [patent_doc_number] => 05607965 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-03-04 [patent_title] => 'Lipoprotein (a) lowering agent, cholesterol lowering agent and medicaments comprising these agents respectively' [patent_app_type] => 1 [patent_app_number] => 8/562994 [patent_app_country] => US [patent_app_date] => 1995-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3537 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/607/05607965.pdf [firstpage_image] =>[orig_patent_app_number] => 562994 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3689047 [patent_doc_number] => 05696170 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-09 [patent_title] => 'Chemical disinfectant based on phenolic active components and glutaraldehyde' [patent_app_type] => 1 [patent_app_number] => 8/553483 [patent_app_country] => US [patent_app_date] => 1995-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1570 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/696/05696170.pdf [firstpage_image] =>[orig_patent_app_number] => 553483 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3770416 [patent_doc_number] => 05773479 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-30 [patent_title] => 'Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells' [patent_app_type] => 1 [patent_app_number] => 8/560808 [patent_app_country] => US [patent_app_date] => 1995-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7842 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/773/05773479.pdf [firstpage_image] =>[orig_patent_app_number] => 560808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4003944 [patent_doc_number] => 05859055 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-01-12 [patent_title] => 'Method of preventing occlusion of arteries' [patent_app_type] => 1 [patent_app_number] => 8/557545 [patent_app_country] => US [patent_app_date] => 1995-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1066 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 47 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/859/05859055.pdf [firstpage_image] =>[orig_patent_app_number] => 557545 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3612566 [patent_doc_number] => 05565444 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-10-15 [patent_title] => 'Osteogenesis promoter and osteoporosis remedy' [patent_app_type] => 1 [patent_app_number] => 8/537743 [patent_app_country] => US [patent_app_date] => 1995-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 12 [patent_no_of_words] => 4286 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/565/05565444.pdf [firstpage_image] =>[orig_patent_app_number] => 537743 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3549260 [patent_doc_number] => 05573761 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1996-11-12 [patent_title] => 'Agent for reducing nephrotoxicity due to medicine' [patent_app_type] => 1 [patent_app_number] => 8/556084 [patent_app_country] => US [patent_app_date] => 1995-11-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3868 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/573/05573761.pdf [firstpage_image] =>[orig_patent_app_number] => 556084 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3695206 [patent_doc_number] => 05650429 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-22 [patent_title] => 'Use of DL-(+/-)-.alpha.-lipoic acid, D-(+)-.alpha.-lipoic acid, .alpha.-lipoic acid in reduced or oxidized form or salts for treating circulatory disorders' [patent_app_type] => 1 [patent_app_number] => 8/554418 [patent_app_country] => US [patent_app_date] => 1995-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2238 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/650/05650429.pdf [firstpage_image] =>[orig_patent_app_number] => 554418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3648821 [patent_doc_number] => 05684040 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-11-04 [patent_title] => 'Compositions in the form of solid solutions' [patent_app_type] => 1 [patent_app_number] => 8/545754 [patent_app_country] => US [patent_app_date] => 1995-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2842 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/684/05684040.pdf [firstpage_image] =>[orig_patent_app_number] => 545754 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3890488 [patent_doc_number] => 05834445 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-10 [patent_title] => 'Process for preparing decolorized carotenoid-cyclodextrin complexes' [patent_app_type] => 1 [patent_app_number] => 8/552374 [patent_app_country] => US [patent_app_date] => 1995-11-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 9841 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/834/05834445.pdf [firstpage_image] =>[orig_patent_app_number] => 552374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3688292 [patent_doc_number] => 05643905 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-01 [patent_title] => 'Pharmaceutical formulation for the treatment of nicotine dependence' [patent_app_type] => 1 [patent_app_number] => 8/495608 [patent_app_country] => US [patent_app_date] => 1995-10-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1961 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/643/05643905.pdf [firstpage_image] =>[orig_patent_app_number] => 495608 [rel_patent_id] =>[rel_patent_doc_number] =>)